In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on Tenaya Therapeutics (TNYA – Research Report). The company’s shares opened today at $1.42. According to TipRanks ...

Original| The Las Vegas Metropolitan Police Department is actively investigating a situation involving a barricaded suspect on the 7200 block of Grand Palace Avenue, near North Tenaya Way and West ...

Begin your TipRanks Premium journey today. Tenaya Therapeutics (TNYA) Company Description: Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Ted Scheinman is a senior editor for Smithsonian magazine. He is the author of Camp Austen: My Life as an Accidental Jane Austen Superfan. The unsung writer, known to many as "Anonymous," led a ...

Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that ...

Analyst Michael Ulz of Morgan Stanley maintained a Buy rating on Tenaya Therapeutics (TNYA – Research Report), retaining the price target of $15.00. Discover outperforming stocks and invest ...